发明名称 |
Compositions and methods for the therapy and diagnosis of influenza |
摘要 |
The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides. |
申请公布号 |
US8974788(B2) |
申请公布日期 |
2015.03.10 |
申请号 |
US201012855553 |
申请日期 |
2010.08.12 |
申请人 |
Theraclone Sciences, Inc. |
发明人 |
Grandea, III Andres G.;King Gordon;Cox Thomas C.;Olsen Ole;Mitcham Jennifer;Moyle Matthew;Hammond Phil |
分类号 |
A61K39/42;A61P31/16;C12Q1/70;G01N33/569;C07K16/10;A61K39/00 |
主分类号 |
A61K39/42 |
代理机构 |
Cooley LLP |
代理人 |
Cooley LLP ;Elrifi Ivor R. |
主权项 |
1. A composition comprising:
(a) an isolated human monoclonal antibody that specifically binds to an epitope of the hemagglutinin (HA) glycoprotein of an influenza virus, wherein said antibody comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 435 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 438; and (b) an isolated human monoclonal antibody that specifically binds to an epitope in the extracellular domain of the matrix 2 ectodomain (M2e) polypeptide of an influenza virus, wherein said antibody comprises a VH CDR1 region comprising the amino acid sequence of NYYWS (SEQ ID NO: 72); a VH CDR2 region comprising the amino acid sequence of FIYYGGNTKYNPSLKS (SEQ ID NO: 74); a VH CDR3 region comprising the amino acid sequence of ASCSGGYCILD (SEQ ID NO: 76); a VL CDR1 region comprising the amino acid sequence of RASQNIYKYLN (SEQ ID NO: 59); a VL CDR2 region comprising the amino acid sequence of AASGLQS (SEQ ID NO: 61); a VL CDR3 region comprising the amino acid sequence of and QQSYSPPLT (SEQ ID NO: 63), and wherein said epitope of the M2e polypeptide is a discontinuous epitope. |
地址 |
Seattle WA US |